| . "Predictive blood-based biomarkers in patients with epithelial ovarian cancer treated with carboplatin and paclitaxel with or without bevacizumab: Results from GOG-0218.." Clin Cancer Res. 2020;26(6):1288-1296. Pub Med |
| . "Randomized, double-blind study comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer.." Future Oncol. 2016;12(11):1359-67. Pub Med |
| . "Multivariate recurrent events in the presence of multivariate informative censoring with applications to bleeding and transfusion events in myelodysplastic syndrome.." J Biopharm Stat. 2014;24(2):429-42. Pub Med |
| . "A comparison of proposed biosimilar LA-EP2006 and reference Pegfilgrastim for the prevention of neutropenia in patients with early-stage breast cancer receiving Myelosuppressive adjuvant or Neoadjuvant chemotherapy: Pegfilgrastim Randomized Oncology (Supp." Oncologist. 2016;21(7):789-94. Pub Med |
| . "Localized differences in caudate and hippocampal shape are associated with schizophrenia but not antipsychotic type.." Psychiatry Res. 2013;211(1):1-10. Pub Med |
| . "Tximeta: Reference sequence checksums for provenance identification in RNA-seq.." PLoS Comput Biol. 2020;16(2):e1007664. Pub Med |
| . "CRM2DIM: A SAS macro for implementing the dual-agent Bayesian continual reassessment method.." Comput Methods Programs Biomed. 2019;176():211-223. Pub Med |
| . "Statistical design of noninferiority multiple region clinical trials to assess global and consistent treatment effects.." J Biopharm Stat. 2017;27(6):933-944. Pub Med |
| . "Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology.." J Pharmacol Exp Ther. 2013;347(3):599-606. Pub Med |
| . "Rare variants association analysis in large-scale sequencing studies at the single locus level.." PLoS Comput Biol. 2016;12(6):e1004993. Pub Med |
| . "Seamless phase IIa/IIb and enhanced dose-finding adaptive design.." J Biopharm Stat. 2016;26(5):912-23. Pub Med |
| . "Cancer pharmacogenomics: early promise, but concerted effort needed.." Science. 2013;339(6127):1563-6. Pub Med |
| . "Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group.." Stat Med. 2015;34(14):2181-95. Pub Med |
| . "A counterfactual p-value approach for benefit-risk assessment in clinical trials.." J Biopharm Stat. 2015;25(3):508-24. Pub Med |
| . "Identifying optimal dosage regimes under safety constraints: An application to long term opioid treatment of chronic pain.." Stat Med. 2018;37(9):1407-1418. Pub Med |
| . "Pharmacogenetics, enzyme probes and therapeutic drug monitoring as potential tools for individualizing taxane therapy.." Pharmacogenomics. 2013;14(5):555-74. Pub Med |
| . "Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy.." Nat Commun. 2020;11(1):6410. Pub Med |
| . "Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.." Eur Heart J. 2016;37(4):412-22. Pub Med |
| . "Meta-analysis methods and models with applications in evaluation of cholesterol-lowering drugs.." Stat Med. 2012;31(28):3597-616. Pub Med |
| . "Bayesian multivariate skew meta-regression models for individual patient data.." Stat Methods Med Res. 2019;28(10-11):3415-3436. Pub Med |
| . "Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer.." Biometrics. 2011;67(4):1422-33. Pub Med |
| . "Efficient methods for signal detection from correlated adverse events in clinical trials.." Biometrics. 2019;75(3):1000-1008. Pub Med |
| . "Phase II cancer clinical trials with heterogeneous patient populations.." J Biopharm Stat. 2012;22(2):312-28. Pub Med |
| . "Onset of persistent pseudomonas aeruginosa infection in children with cystic fibrosis with interval censored data.." BMC Med Res Methodol. 2016;16(1):122. Pub Med |
| . "Enrollment and stopping rules for managing toxicity requiring long follow-up in phase II oncology trials.." J Biopharm Stat. 2015;25(6):1206-14. Pub Med |
| . "Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells.." J Biol Chem. 2019;294(15):5914-5922. Pub Med |
| . "Intergenerational response to the endocrine disruptor vinclozolin is influenced by maternal genotype and crossing scheme.." Reprod Toxicol. 2018;78():9-19. Pub Med |
| . "Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells.." J Biol Chem. 2019;294(15):5914-5922. Pub Med |
| . "K-Sample comparisons using propensity analysis.." Biom J. 2019;61(3):698-713. Pub Med |
| . "Bayesian design of biosimilars clinical programs involving multiple therapeutic indications.." Biometrics. 2020;76(2):630-642. Pub Med |
| . "Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial.." Biostatistics. 2011;12(2):258-69. Pub Med |
| . "Phase II cancer clinical trials for biomarker-guided treatments.." J Biopharm Stat. 2018;28(2):256-263. Pub Med |
| . "A counterfactual p-value approach for benefit-risk assessment in clinical trials.." J Biopharm Stat. 2015;25(3):508-24. Pub Med |
| . "On enrichment strategies for biomarker stratified clinical trials.." J Biopharm Stat. 2018;28(2):292-308. Pub Med |
| . "Flexible stopping boundaries when changing primary endpoints after unblinded interim analyses.." J Biopharm Stat. 2014;24(4):817-33. Pub Med |
| . "Multitrial evaluation of progression-free survival as a surrogate end point for overall survival in first-line extensive-stage small-cell lung cancer.." J Thorac Oncol. 2015;10(7):1099-106. Pub Med |
| . "Efficient estimation of the distribution of time to composite endpoint when some endpoints are only partially observed.." Lifetime Data Anal. 2013;19(4):513-46. Pub Med |
| . "A novel test to compare two treatments based on endpoints involving both nonfatal and fatal events.." Pharm Stat. 2015;14(4):273-83. Pub Med |
| . "Multiple testing of treatment-effect-modifying biomarkers in a randomized clinical trial with a survival endpoint.." Stat Med. 2011;30(13):1502-18. Pub Med |
| . "Meta-analysis methods and models with applications in evaluation of cholesterol-lowering drugs.." Stat Med. 2012;31(28):3597-616. Pub Med |
| . "Assessing temporal agreement between central and local progression-free survival times.." Stat Med. 2015;34(5):844-58. Pub Med |
| . "Static and dynamic DNA loops form AP-1-bound activation hubs during macrophage development.." Mol Cell. 2017;67(6):1037-1048.e6. Pub Med |
| . "Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial.." Biostatistics. 2011;12(2):258-69. Pub Med |
| . "Studying gene and gene-environment effects of uncommon and common variants on continuous traits: a marker-set approach using gene-trait similarity regression.." Am J Hum Genet. 2011;89(2):277-88. Pub Med |
| . "A general framework for studying genetic effects and gene-environment interactions with missing data.." Biostatistics. 2010;11(4):583-98. Pub Med |
| . "Analysis of untyped SNPs: Maximum likelihood and imputation methods.." Genet Epidemiol. 2010;34(8):803-15. Pub Med |
| . "Complete effect-profile assessment in association studies with multiple genetic and multiple environmental factors.." Genet Epidemiol. 2015;39(2):122-33. Pub Med |
| . "Estimating effect of environmental contaminants on women's subfecundity for the MoBa study data with an outcome-dependent sampling scheme.." Biostatistics. 2014;15(4):636-50. Pub Med |
| . "Using structural equation modeling to assess the links between tobacco smoke exposure, volatile organic compounds, and respiratory function for adolescents aged 6 to 18 in the United States.." Int J Environ Res Public Health. 2017;14(10):. Pub Med |
| . "Using structural equation modeling to assess the links between tobacco smoke exposure, volatile organic compounds, and respiratory function for adolescents aged 6 to 18 in the United States.." Int J Environ Res Public Health. 2017;14(10):. Pub Med |
